Journal Article10.1016/S0140-6736(01)05349-1
Oral amiodarone and atrial fibrillation
3
About: This article is published in The Lancet. The article was published on 14 Jul 2001. The article focuses on the topics: Amiodarone & Atrial fibrillation.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Amiodarone - excellent antiarrhythmic drug? (Happy end after 40 years of problems)
TL;DR: Amiodarone is a drug which is capable with high probability of anticipat ing arrhythmias, combining, in an exclusive exceptional entity, beneficial effects on cardiac electrophysiology, neurochemical parameters, coronary flow and haemodynamics with a unique local antithyroid effect.
3
On human self-domestication, psychiatry, and eugenics.
TL;DR: The example of human self-domestication may illustrate that scientific ideas, especially when dealing with human biology, are prone to misuse, particularly if "is" is confused with "ought", if moral principles are deduced from biological facts.
Healthy diet in Canadians of low socioeconomic status with coronary heart disease: Not just a matter of knowledge and choice
TL;DR: Food consumption and diet were not principally related to knowledge but were constrained by an ever-present scarcity of resources and the need to prioritize other daily living expenses perceived as being more important than diet.
References
Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation.
Jonathan M. Kalman,Muhammad Munawar,Laurence G. Howes,William J Louis,Brain F. Buxton,Geoffrey A Gutteridge,Andrew M. Tonkin +6 more
TL;DR: Elevated norepinephrine levels suggest that sympathetic activation may be important in the pathogenesis of atrial fibrillation after coronary artery bypass grafting, and this underlines the importance of beta-adrenoceptor blockade as prophylaxis.
381
Dose-Ranging Study of Intravenous Amiodarone in Patients With Life-Threatening Ventricular Tachyarrhythmias
Melvin M. Scheinman,Joseph H. Levine,David S. Cannom,Ted Friehling,Harry A. Kopelman,Donald A. Chilson,Edward V. Platia,David J. Wilber,Peter R. Kowey +8 more
TL;DR: The goal of this study was to demonstrate the efficacy of intravenous amiodarone in patients with refractory, recurrent hemodynamically destabilizing ventricular tachycardia or ventricular fibrillation by determining a dose response among three regimens.
252
Amiodarone interaction with beta-blockers: analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databases. The EMIAT and CAMIAT Investigators.
Florent Boutitie,Jean-Pierre Boissel,Stuart J. Connolly,Alan John Camm,John A. Cairns,Desmond G. Julian,Michael Gent,Michiel J. Janse,Paul Dorian,G Frangin +9 more
TL;DR: In this article, the authors explore if an interaction with β-blocker treatment plays a role in the decrease of cardiac arrhythmic deaths with amiodarone in patients recovered from an acute myocardial infarction.
221
Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting.
Maarten J. Suttorp,J.Herre Kingma,Hans O Peels,Egbert M. Koomen,Jan G.P. Tijssen,Norbert M. van Hemel,Jo J.A.M. Defauw,Sjef M.P.G. Ernst +7 more
TL;DR: Univariate analysis indicated that older age, 1- or 2-vessel coronary artery disease, long bypass and aorta cross-clamp time were predictive variables for the occurrence of SVTs and Multivariate analysis showed that male sex, older age and male sex were independent risk factors for increased occurrence of postoperative SVT.
132
Prophylactic oral amiodarone compared with placebo for prevention of atrial fibrillation after coronary artery bypass surgery
Joseph D. Redle,Sandeep Khurana,Rey Marzan,Peter A. McCullough,James R. Stewart,Douglas C. Westveer,William W. O'Neill,Joseph Bassett,Nicholas A. Tepe,Howard I. Frumin +9 more
TL;DR: Prophylactic oral amiodarone did not statistically alter the incidence or duration of atrial fibrillation after CABG, although favorable trends were noted.
124